A Rapid and Sensitive UPLC-MS/MS Method for Quantification of Bruceantinol in Rat Plasma and Its Application to a Pharmacokinetic Study

Abstract

Bruceantinol (BOL), a quassinoid compound isolated from the fruits of Brucea javanica, has been reported to have cytotoxic and antibacterial effects. In this study, a rapid, sensitive, and specific ultra-performance liquid chromatography with tandem mass spectrometry (UPLC-MS/MS) method was developed for the quantitative determination of BOL in rat plasma. The samples were treated by simple liquid-liquid extraction with ethyl acetate and separated on an UPLC BEH C18 column (2.1 mm × 50 mm) using a 3-min gradient elution scheme, which consists of water (0.1% v/v, formic acid) and methanol (0.1%, v/v, formic acid) to achieve the separation of BOL and sinomenine (IS) with high selectivity. The electrospray ionization source was used in positive ion mode; the multiple reaction monitoring quantified the target fragment ions m/z 629.6 → 569.5 for BOL and m/z 330.5 → 207.3 for IS. This work was evaluated with regards to the specificity, extraction recovery, matrix effect, linearity, accuracy, precision, stability, and dilution integrity. This approach was used to examine the pharmacokinetics of BOL in rats after oral (0.3 mg/kg) and intravenous (0.15 mg/kg) administration. BOL presented fast excretion and very low oral bioavailability.

Key words

bruceantinol - UPLC-MS/MS - pharmacokinetics - bioavailability - Brucea javanica - Simaroubaceae

• References

• 1 Liu JH, Zhao N, Zhang GJ, Yu SS, Wu LJ, Qu J, Ma SG, Chen XG, Zhang TQ, Bai J, Chen H, Fang ZF, Zhao F. Bioactive quassinoids from the seeds of Brucea javanica . J Nat Prod 2012; 75: 683-688
• 2 OʼNeill MJ, Bray DH, Boardman P, Chan KL, Phillipson JD, Warhurst DC, Peters W. Plants as sources of antimalarial drugs, part 4: activity of Brucea javanica fruits against chloroquine-resistant plasmodium falciparum in vitro and against plasmodium berghei in vivo . J Nat Prod 1987; 50: 41-48
• 3 Liu TT, Mu LQ, Dai W, Wang CB, Liu XY, Xiang DX. Preparation, characterization, and evaluation of antitumor effect of Brucea javanica oil cationic nanoemulsions. Int J Nanomed 2016; 11: 2515-2529
• 4 Zhang ZK, Ouyang M, Zhan JS, Wu ZJ. Quassinoids from Brucea javanica seeds inhibiting the replication of tobacco mosaic virus. Curr Bioact Compd 2013; 9: 247-254
• 5 Kupchan SM, Britton RW, Lacadie JA, Ziegler MF, Sigel CW. Tumor inhibitors. 100. Isolation and structural elucidation of bruceantin and bruceantinol, new potent antileukemic quassinoids from Brucea antidysenterica . J Org Chem 1975; 40: 648-654
• 6 Elkhateeb A, Tosa Y, Matsuura H, Nabeta K, Katakura K. Antitrypanosomal activities of acetylated bruceines A and C; a structure-activity relationship study. J Nat Med 2012; 66: 233-240
• 7 Ye QM, Bai LL, Hu SZ, Tian HY, Ruan LJ, Tan YF, Hu LP, Ye WC, Zhang DM, Jiang RW. Isolation, chemotaxonomic significance and cytotoxic effects of quassinoids from Brucea javanica . Fitoterapia 2015; 105: 66-72
• 8 Bawm S, Matsuura H, Elkhateeb A, Nabeta K, Subeki. Nonaka N, Oku Y, Katakura K. In vitro antitrypanosomal activities of quassinoid compounds from the fruits of a medicinal plant, Brucea javanica . Vet Parasitol 2008; 158: 288-294
• 9 Subeki. Matsuura H, Takahashi K, Nabeta K, Yamasaki M, Maede Y, Katakura K. Screening of Indonesian medicinal plant extracts for antibabesial activity and isolation of new quassinoids from Brucea javanica . J Nat Prod 2007; 70: 1654-1657
• 10 Lau ST, Lin ZX, Liao Y, Zhao M, Cheng CH, Leung PS. Brucein D induces apoptosis in pancreatic adenocarcinoma cell line PANC-1 through the activation of p38-mitogen activated protein kinase. Cancer Lett 2009; 281: 42-52
• 11 Ren D, Villeneuve NF, Jiang T, Wu T, Lau A, Toppin HA, Zhang DD. Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism. P Natl Acad Sci U S A 2011; 108: 1433-1438
• 12 Wang Y, Wu ZF, Wang GX, Wang F, Liu YT, Li FY, Han J. In vivo anthelmintic activity of bruceine A and bruceine D from Brucea javanica against Dactylogyrus intermedius (Monogenea) in goldfish (Carassius auratus). Vet Parasitol 2011; 177: 127-133
• 13 Issa ME, Berndt S, Carpentier G, Pezzuto JM, Cuendet M. Bruceantin inhibits multiple myeloma cancer stem cell proliferation. Cancer Biol Ther 2016; 17: 966-975
• 14 Suling WJ, Woolley CW, Shannon WM. Disposition and metabolism of bruceantin in the mouse. Cancer Chemoth Pharm 1979; 3: 171-176
• 15 Wiseman CL, Yap HY, Bedikian AY, Bodey GP, Blumenschein GR. Phase II trial of bruceantin in metastatic breast carcinoma. Am J Clin Onco 1982; 5: 389-391
• 16 Arseneau JC, Wolter JM, Kuperminc M, Ruckdeschel JC. A phase II study of bruceantin (NSC-165, 563) in advanced malignant melanoma. Invest New Drug 1983; 1: 239-242
• 17 Fan J, Guan L, Kou Z, Feng F, Zhang Y, Liu W. Determination of chrysotoxine in rat plasma by liquid chromatography-tandem mass spectrometry and its application to a rat pharmacokinetic study. J Chromatogr B 2014; 967: 57-62
• 18 U.S. Department of Health and Human Services, Food and Drug Administration. Guidance for Industry: Bioanalytical Method Validation. Rockville: Center for Drug Evaluation and Research; 2013